At a glance
ClinicalIndex Comparison RecordN/ACompleted· 1,421 enrolled
Drug / intervention
None administered in this studybiological
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Post-licensure Safety Surveillance Study of Routine Use of Meningococcal (Groups A, C, Y, and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine (Menactra®) in Recipients 2 to 10 Years of Age.
In Brief
An observational study evaluating None administered in this study for Meningitis and Meningococcal Disease. Completed, enrolled 1,421 participants across 1 site.
Detailed Summary
To further characterize the safety profile of Menactra vaccine and to identify any signals of potentially vaccine-related adverse events (AEs) not detected during pre-licensure studies.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsMeningitis, Meningococcal Disease
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartJul 2005
First PostedAug 2008
Primary CompletionMay 2013
TodayJul 2026
First PostedAug 5, 2008
Enrollment StartJul 1, 2005
Primary CompletionMay 1, 2013
TodayJul 2, 2026
Enrollment to primary: 7.8 yearsPosted 17.9 years ago
Interventions
None administered in this studybiological
N/A in this study